| Name | 2-pyrimidin-2-ylacetonitrile |
|---|---|
| Synonyms |
2-(Pyrimidin-2-yl)acetonitrile
2-Pyrimidineacetonitrile 2-Pyrimidinylacetonitrile Pyrimidin-2-ylacetonitrile |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 228.5±23.0 °C at 760 mmHg |
| Molecular Formula | C6H5N3 |
| Molecular Weight | 119.124 |
| Flash Point | 91.4±7.8 °C |
| Exact Mass | 119.048347 |
| PSA | 49.57000 |
| LogP | -0.57 |
| Vapour Pressure | 0.1±0.5 mmHg at 25°C |
| Index of Refraction | 1.537 |
| Hazard Codes | T+ |
|---|---|
| Risk Phrases | 23/24/25 |
| Safety Phrases | 36/37/39-45 |
| HS Code | 2933599090 |
|
~61%
59566-45-9 |
| Literature: Amgen Inc. Patent: US2007/299080 A1, 2007 ; Location in patent: Page/Page column 80-81 ; |
|
~%
59566-45-9 |
| Literature: SmithKline Corporation Patent: US3966945 A1, 1976 ; |
| Precursor 3 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |